These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24180408)

  • 21. Antibiotic susceptibility of Helicobacter pylori in Iceland.
    Gunnarsdottir AI; Gudjonsson H; Hardardottir H; Jonsdottir KD; Bjornsson ES
    Infect Dis (Lond); 2017 Sep; 49(9):647-654. PubMed ID: 28440099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice.
    Fiorini G; Zullo A; Saracino IM; Gatta L; Pavoni M; Vaira D
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):621-625. PubMed ID: 29481383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study.
    Liang X; Xu X; Zheng Q; Zhang W; Sun Q; Liu W; Xiao S; Lu H
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):802-7.e1. PubMed ID: 23376004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Helicobacter pylori - 2012].
    Buzás GM
    Orv Hetil; 2012 Sep; 153(36):1407-18. PubMed ID: 22951408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attempts to enhance the eradication rate of Helicobacter pylori infection.
    Bang CS; Baik GH
    World J Gastroenterol; 2014 May; 20(18):5252-62. PubMed ID: 24833855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori-related diseases.
    Gisbert JP
    Gastroenterol Hepatol; 2016 Sep; 39 Suppl 1():36-46. PubMed ID: 27888863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea.
    Kim SY; Lee SW; Choe JW; Jung SW; Hyun JJ; Jung YK; Koo JS; Yim HJ
    Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28940815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seven-day triple therapy is a better choice for Helicobacter pylori eradication in regions with low antibiotic resistance.
    Tong YF; Lv J; Ying LY; Xu F; Qin B; Chen MT; Meng F; Tu MY; Yang NM; Li YM; Zhang JZ
    World J Gastroenterol; 2015 Dec; 21(46):13073-9. PubMed ID: 26672777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Favorable outcomes of culture-based Helicobacter pylori eradication therapy in a region with high antimicrobial resistance.
    Lee JW; Kim N; Nam RH; Lee SM; Kwon YH; Sohn SD; Kim JM; Lee DH; Jung HC
    Helicobacter; 2019 Apr; 24(2):e12561. PubMed ID: 30632237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Sep; 34(6):604-17. PubMed ID: 21745241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrolide use in the previous years is associated with failure to eradicate Helicobacter pylori with clarithromycin-containing regimens.
    Muñoz-Gómez P; Jordán-Castro JA; Abanades-Tercero M; Blanco-González JJ; Andrés Esteban EM; Valle-Muñoz J
    Helicobacter; 2018 Feb; 23(1):. PubMed ID: 29178562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.
    Miftahussurur M; Shrestha PK; Subsomwong P; Sharma RP; Yamaoka Y
    BMC Microbiol; 2016 Nov; 16(1):256. PubMed ID: 27809767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.
    Sugimoto M; Uotani T; Sahara S; Ichikawa H; Yamade M; Sugimoto K; Furuta T
    Helicobacter; 2014 Aug; 19(4):312-8. PubMed ID: 24690010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
    Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
    Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
    Marzio L; Coraggio D; Capodicasa S; Grossi L; Cappello G
    Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.
    Miftahussurur M; Yamaoka Y
    Molecules; 2015 Apr; 20(4):6068-92. PubMed ID: 25856059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
    Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
    Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori Primary Antibiotic Resistance in 2015 in Morocco: A Phenotypic and Genotypic Prospective and Multicenter Study.
    Bouihat N; Burucoa C; Benkirane A; Seddik H; Sentissi S; Al Bouzidi A; Elouennas M; Benouda A
    Microb Drug Resist; 2017 Sep; 23(6):727-732. PubMed ID: 27996373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance.
    Cosme A; Lizasoan J; Montes M; Tamayo E; Alonso H; Mendarte U; Martos M; Fernández-Reyes M; Saraqueta C; Bujanda L
    Helicobacter; 2016 Feb; 21(1):29-34. PubMed ID: 25982426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Helicobacter pylori infection: Where are we now?
    Liou JM; Wu MS; Lin JT
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1918-1926. PubMed ID: 27088632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.